AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25950425 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo capsules and lidocaine 1 mg/kg intravenous bolus dose followed by 2 mg/kg/h infusion until skin closure
Number of subjects: 80
Study 25950425 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg oral pregabalin and normal saline infusion perioperatively
Number of subjects: 80
Study 25950425 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg oral pregabalin and lidocaine 2 mg/kg/h infusion until skin closure
Number of subjects: 80
Study 23395119 — intervention group
Group type: EXPERIMENTAL
Intervention: One delayed intensification course
Number of subjects: 521
Study 23395119 — intervention group
Group type: COMPARATOR
Intervention: Two delayed intensification courses
Number of subjects: 521
Study 20692182 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention arm (Health Belief Model telephonic intervention)
Number of subjects: 227
Study 20692182 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention arm
Number of subjects: 227
Study 20692182 — intervention group
Group type: COMPARATOR
Intervention: Attention control arm
Number of subjects: 227
Study 20492127 — intervention group
Group type: EXPERIMENTAL
Intervention: WYPF banana bread
Number of subjects: 0
Study 20492127 — intervention group
Group type: EXPERIMENTAL
Intervention: WYPF biscotti
Number of subjects: 0
Study 20492127 — intervention group
Group type: EXPERIMENTAL
Intervention: BYP (Boiled Yellow Peas)
Number of subjects: 0
Study 20492127 — intervention group
Group type: EXPERIMENTAL
Intervention: WYPF pasta
Number of subjects: 0
Study 20492127 — intervention group
Group type: COMPARATOR
Intervention: WWF biscotti
Number of subjects: 0
Study 20492127 — intervention group
Group type: COMPARATOR
Intervention: WB (White Bread)
Number of subjects: 0
Study 20492127 — intervention group
Group type: COMPARATOR
Intervention: WWF pasta
Number of subjects: 0
Study 17276096 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 128
Study 12850965 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 812
Study 12850965 — intervention group
Group type: EXPERIMENTAL
Intervention: Black women
Number of subjects: 812
Study 12850965 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-thigh muscle area
Number of subjects: 812
Study 12850965 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle area
Number of subjects: 812
Study 12850965 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 812
Study 12850965 — intervention group
Group type: COMPARATOR
Intervention: Four groups (White men, White women, Black men, Black women)
Number of subjects: 812
Study 10570388 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (dosed twice daily, once daily, and 3 times weekly)
Number of subjects: 35
Study 10570388 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (dosed twice weekly)
Number of subjects: 35
Study 10570388 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (dosed once weekly)
Number of subjects: 35
Study 10570388 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream (control)
Number of subjects: 35
Study 8932457 — intervention group
Group type: EXPERIMENTAL
Intervention: Test suspensions
Number of subjects: 0
Study 8932457 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 0
Study 1881558 — intervention group
Group type: EXPERIMENTAL
Intervention: Picotamide (900 mg/die)
Number of subjects: 25
Study 1881558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 7051249 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ) 160 mg of TMP plus 800 mg of SMZ daily for four months
Number of subjects: 52
Study 7051249 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 52
Study 31470971 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention group (AG) - integrated intervention program
Number of subjects: 368
Study 31470971 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive intervention group (PG) - oral health-related information and activity record cards
Number of subjects: 368
Study 31470971 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - received only a lecture
Number of subjects: 368
Study 31470971 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention group (AG)
Number of subjects: 368
Study 31470971 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive intervention group (PG)
Number of subjects: 368
Study 31470971 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 368
Study 28453701 — intervention group
Group type: EXPERIMENTAL
Intervention: Radium-223
Number of subjects: 921
Study 28453701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study 26556074 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration training
Number of subjects: 30
Study 26556074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 24340770 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication based on antlers of Siberian stags
Number of subjects: 0
Study 21278140 — intervention group
Group type: EXPERIMENTAL
Intervention: NAFLD group
Number of subjects: 7849
Study 21278140 — intervention group
Group type: COMPARATOR
Intervention: Non-NAFLD group
Number of subjects: 7849
Study 21278140 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose group with NAFLD
Number of subjects: 7849
Study 19833861 — intervention group
Group type: EXPERIMENTAL
Intervention: Laropiprant with extended-release niacin
Number of subjects: 0
Study 19833861 — intervention group
Group type: COMPARATOR
Intervention: Extended-release niacin alone
Number of subjects: 0
Study 19833861 — intervention group
Group type: COMPARATOR
Intervention: Laropiprant alone
Number of subjects: 0
Study 16380313 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent feedback
Number of subjects: 38
Study 16380313 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent feedback
Number of subjects: 38
Study 15154607 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 g daily GLA (borage oil)
Number of subjects: 24
Study 15154607 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (placebo)
Number of subjects: 24
Study 10631624 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin 2 mg tablet
Number of subjects: 24
Study 10631624 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 24
Study 9181630 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (50, 100 and 200 mg)
Number of subjects: 7
Study 9181630 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.125, 0.25, 0.50 mg)
Number of subjects: 7
Study 9181630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 1373007 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (7.5% NaCl)
Number of subjects: 105
Study 1373007 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline plus dextran (7.5% NaCl plus 6% dextran 70)
Number of subjects: 105
Study 1373007 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 105
Study 2857210 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 50 mg twice a day
Number of subjects: 14
Study 2857210 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 80 mg twice a day
Number of subjects: 14
Study 2857210 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of hydrochlorothiazide and propranolol
Number of subjects: 14
Study 30893841 — intervention group
Group type: EXPERIMENTAL
Intervention: Curtailed night (CN)
Number of subjects: 24
Study 28847038 — intervention group
Group type: EXPERIMENTAL
Intervention: Leicester PPH predict score
Number of subjects: 24230
Study 28515369 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive lipid- and blood pressure-lowering therapy
Number of subjects: 68
Study 26713871 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated local stakeholder groups for improved neonatal survival
Number of subjects: 0
Study 26713871 — intervention group
Group type: COMPARATOR
Intervention: Control area (no intervention)
Number of subjects: 0
Study 24634929 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative carbohydrate-rich beverage (fed group)
Number of subjects: 0
Study 24634929 — intervention group
Group type: COMPARATOR
Intervention: Nothing by mouth (fasting group)
Number of subjects: 0
Study 22170452 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care workshops over the course of 2 months
Number of subjects: 74
Study 22170452 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 74
Study 18319412 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (30-minute infusion of 1000 mg/m2 once per week for 3 weeks prior to chemoradiation and for 12 weeks after chemoradiation)
Number of subjects: 451
Study 18319412 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil (continuous infusion of 250 mg/m2 per day for 3 weeks prior to chemoradiation and for 12 weeks after chemoradiation)
Number of subjects: 451
Study 18319412 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 451
Study 18319412 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil
Number of subjects: 451
Study 16870074 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 μg/h fentanyl transdermal system (fentanyl TTS)
Number of subjects: 227
Study 12673712 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide, ifosfamide, and cisplatin (VIP)
Number of subjects: 286
Study 12673712 — intervention group
Group type: COMPARATOR
Intervention: Bleomycin, etoposide, and cisplatin (BEP)
Number of subjects: 286
Study 10897509 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacist-managed repeat prescribing system
Number of subjects: 3074
Study 10897509 — intervention group
Group type: COMPARATOR
Intervention: Established methods of managing repeat prescribing
Number of subjects: 3074
Study 9050128 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking (as an intervention)
Number of subjects: 90
Study 9050128 — intervention group
Group type: COMPARATOR
Intervention: Nonsmoking (as a control)
Number of subjects: 90
Study 9050128 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptic doses
Number of subjects: 90
Study 9050128 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 90
Study 8416329 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ambulation (group A) 6 hours after catheterization
Number of subjects: 273
Study 8416329 — intervention group
Group type: COMPARATOR
Intervention: Late ambulation (group B) the following morning
Number of subjects: 273
Study 3532010 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized metaproterenol
Number of subjects: 35
Study 3532010 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized metaproterenol (second treatment)
Number of subjects: 35
Study 3532010 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous epinephrine
Number of subjects: 35
Study 29860500 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid/heparin infusion
Number of subjects: 10
Study 29860500 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 10
Study 27381665 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Replacement (TAVR)
Number of subjects: 353
Study 27381665 — intervention group
Group type: COMPARATOR
Intervention: Surgical Aortic Valve Replacement (SAVR)
Number of subjects: 353
Study 23969265 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp protocol with 20% reduced contrast dose
Number of subjects: 100
Study 23969265 — intervention group
Group type: COMPARATOR
Intervention: 120 kVp protocol (control group)
Number of subjects: 100
Study 23969265 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp protocol
Number of subjects: 100
Study 22107850 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY‐TT and HepA/B (Twinrix) co-administered
Number of subjects: 611
Study 22107850 — intervention group
Group type: COMPARATOR
Intervention: MenACWY‐TT alone
Number of subjects: 611
Study 22107850 — intervention group
Group type: COMPARATOR
Intervention: HepA/B (Twinrix) alone
Number of subjects: 611
Study 20831889 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral-appliance therapy
Number of subjects: 103
Study 20831889 — intervention group
Group type: COMPARATOR
Intervention: CPAP therapy
Number of subjects: 103
Study 19087312 — intervention group
Group type: EXPERIMENTAL
Intervention: Water gargling
Number of subjects: 252
Study 19087312 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 252
Study 17121041 — intervention group
Group type: EXPERIMENTAL
Intervention: Yunpi Zhixie Granule (YZG)
Number of subjects: 300
Study 17121041 — intervention group
Group type: COMPARATOR
Intervention: Smacta (Control)
Number of subjects: 300
Study 12834936 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg pethidine
Number of subjects: 59
Study 12834936 — intervention group
Group type: COMPARATOR
Intervention: 100 mg tramadol
Number of subjects: 59
Study 12834936 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study 10634681 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive prevention (counseling, F‐varnish applications, F‐lozenges, sealants, chlorhexidine)
Number of subjects: 1465
Study 10634681 — intervention group
Group type: COMPARATOR
Intervention: Basic prevention (counseling, one F‐varnish application/year)
Number of subjects: 1465
Study 7707278 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine
Number of subjects: 0
Study 7707278 — intervention group
Group type: COMPARATOR
Intervention: Cinnarizine
Number of subjects: 0
Study 2764852 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg, t.i.d.)
Number of subjects: 12
Study 2764852 — intervention group
Group type: COMPARATOR
Intervention: Placebo (t.i.d.)
Number of subjects: 12
Study 360903 — intervention group
Group type: COMPARATOR
Intervention: 5% ribavirin in ointment base
Number of subjects: 390
Study 360903 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 390
Study 31424713 — intervention group
Group type: EXPERIMENTAL
Intervention: Halobetasol 0.01%/Tazarotene 0.045% lotion (HP/TAZ)
Number of subjects: 418
Study 31424713 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 418
Study 28151877 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patients training
Number of subjects: 242
Study 28151877 — intervention group
Group type: COMPARATOR
Intervention: Traditional small group seminars
Number of subjects: 242
Study 25614945 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrabeam device delivering 14 Gy to a 2-mm depth during surgery
Number of subjects: 23
Study 23894178 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted educational intervention including two visits by peer academic detailers and regional seminars.
Number of subjects: 382
Study 23894178 — intervention group
Group type: COMPARATOR
Intervention: Control intervention targeting prescribing practice for older patients.
Number of subjects: 382
Study 20619489 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0
Study 20619489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18199805 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer hydrochloride
Number of subjects: 119
Study 18199805 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate
Number of subjects: 119
Study 16521770 — intervention group
Group type: EXPERIMENTAL
Intervention: Various numbers of equal log‐ or ERBN‐width subbands
Number of subjects: 0
Study 16521770 — intervention group
Group type: EXPERIMENTAL
Intervention: Partition bandwidth corresponding to asymptotic performance
Number of subjects: 0
Study 16521770 — intervention group
Group type: EXPERIMENTAL
Intervention: Partition bandwidths at asymptote in low-frequency region
Number of subjects: 0
Study 12760443 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 594
Study 12760443 — intervention group
Group type: COMPARATOR
Intervention: Other weight-reducing diets
Number of subjects: 594
Study 12760443 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet and other weight-reducing diets
Number of subjects: 594
Study 11125309 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine treatment
Number of subjects: 0
Study 11125309 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated HIV-1 infected pregnant women
Number of subjects: 0
Study 11125309 — intervention group
Group type: COMPARATOR
Intervention: Healthy women
Number of subjects: 0
Study 11125309 — intervention group
Group type: COMPARATOR
Intervention: HIV-1 infected groups
Number of subjects: 0
Study 9326127 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation during and after cardiac surgery
Number of subjects: 0
Study 9326127 — intervention group
Group type: COMPARATOR
Intervention: Cardiac surgery
Number of subjects: 0
Study 8466427 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (E) - vinyl urinary bags reused for 4 weeks with daily decontamination using dilute bleach rinse
Number of subjects: 54
Study 8466427 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) - vinyl urinary bags replaced weekly
Number of subjects: 54
Study 3026052 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (40 mg orally four times daily)
Number of subjects: 190
Study 3026052 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (10 mg orally twice daily)
Number of subjects: 190
Study 3026052 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate after crossover from tamoxifen
Number of subjects: 190
Study 3026052 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen after crossover from megestrol acetate
Number of subjects: 190
Study 30734195 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyloric injection of magnesium sulfate-lidocaine mixture
Number of subjects: 70
Study 30734195 — intervention group
Group type: COMPARATOR
Intervention: Pyloric injection of normal saline (control)
Number of subjects: 70
Study 29316213 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan/cilnidipine
Number of subjects: 129
Study 29316213 — intervention group
Group type: COMPARATOR
Intervention: Valsartan/hydrochlorothiazide
Number of subjects: 129
Study 27438870 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinnitus Masking (TM)
Number of subjects: 148
Study 27438870 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinnitus Retraining Therapy (TRT)
Number of subjects: 148
Study 27438870 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinnitus Educational Counseling (TED)
Number of subjects: 148
Study 27438870 — intervention group
Group type: COMPARATOR
Intervention: Wait-list Control (WLC)
Number of subjects: 148
Study 24695720 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) applied to the right cerebellum
Number of subjects: 0
Study 24695720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (tDCS) applied to the right cerebellum
Number of subjects: 0
Study 24695720 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 0
Study 22503163 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase - Decrease group
Number of subjects: 88
Study 22503163 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase group
Number of subjects: 88
Study 22503163 — intervention group
Group type: COMPARATOR
Intervention: Minimum Intervention group
Number of subjects: 88
Study 20113397 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil 10 mg
Number of subjects: 0
Study 20113397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18806039 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation with PEEP (10 cm H2O)
Number of subjects: 0
Study 18806039 — intervention group
Group type: COMPARATOR
Intervention: Ventilation with zero end-expiratory pressure
Number of subjects: 0
Study 18806039 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing end-expiratory pressure in isolated perfused mouse lungs (IPL)
Number of subjects: 0
Study 16202958 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion sustained release (SR)
Number of subjects: 44
Study 16202958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 11933664 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional treatment
Number of subjects: 40
Study 11933664 — intervention group
Group type: COMPARATOR
Intervention: Intermaxillary fixation
Number of subjects: 40
Study 10075322 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially defatted flaxseed (approximately 50 g partially defatted flaxseed/d)
Number of subjects: 29
Study 10075322 — intervention group
Group type: COMPARATOR
Intervention: Wheat bran (control)
Number of subjects: 29
Study 8549576 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric contractions (CL)
Number of subjects: 10
Study 8549576 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric contractions (EL)
Number of subjects: 10
Study 1898585 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin intranasally twice daily for 5 days
Number of subjects: 68
Study 1898585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 6648120 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental health education
Number of subjects: 0
Study 6648120 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental delivery
Number of subjects: 0
Study 31401909 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST-PC)
Number of subjects: 352
Study 28279086 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for weight loss (0, 1, 2, or 3 incentives awarded quarterly over 1 year)
Number of subjects: 544
Study 28279086 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for medication compliance (0, 1, 2, or 3 incentives awarded quarterly over 1 year)
Number of subjects: 544
Study 28279086 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for physical activity (0, 1, 2, or 3 incentives awarded quarterly over 1 year)
Number of subjects: 544
Study 28279086 — intervention group
Group type: COMPARATOR
Intervention: Financial incentives (0, 1, 2, or 3 incentives awarded quarterly over 1 year)
Number of subjects: 544